Abstract
ABSTRACT While standardized microdilution testing methodologies and quality control ranges exist for the novel glycolipopeptide dalbavancin, no testing methods have been described that are immediately available for routine use in clinical laboratories. In this study, we found that the dalbavancin Etest (AB BIODISK, Solna, Sweden) procedure demonstrated a high degree of agreement (100% within ±2 log 2 dilution steps) with the standardized broth microdilution method, validating the use of the Etest as an alternative test for investigational or clinical purposes following regulatory approval.
Keywords
Affiliated Institutions
Related Publications
Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria
The E Test (AB Biodisk, Solna, Sweden) is a new method for performing antimicrobial susceptibility tests. It consists of an impervious carrier (5- by 50-mm strip) with a predefi...
Antimicrobial Susceptibility Testing: A Review of General Principles and Contemporary Practices
An important task of the clinical microbiology laboratory is the performance of antimicrobial susceptibility testing of significant bacterial isolates. The goals of testing are ...
In Vitro Antibacterial Properties of Pexiganan, an Analog of Magainin
ABSTRACT Pexiganan, a 22-amino-acid antimicrobial peptide, is an analog of the magainin peptides isolated from the skin of the African clawed frog. Pexiganan exhibited in vitro ...
Clinical Importance of Identifying Coagulase-Negative Staphylococci Isolated from Blood Cultures: Evaluation of MicroScan Rapid and Dried Overnight Gram-Positive Panels versus a Conventional Reference Method
ABSTRACT We evaluated the clinical usefulness of species identification of blood isolates of coagulase-negative staphylococci as a predictor of the clinical significance of the ...
Comparison of Two Methods and Three End Points in Determination of In Vitro Activity of Micafungin against <i>Aspergillus</i> spp
ABSTRACT We investigated the in vitro activity of micafungin against clinical Aspergillus isolates ( n = 37) ( Aspergillusfumigatus [ n = 21], Aspergillusflavus [ n = 14], and A...
Publication Info
- Year
- 2006
- Type
- article
- Volume
- 44
- Issue
- 8
- Pages
- 2988-2990
- Citations
- 30
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1128/jcm.00640-06
- PMID
- 16891523